LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $54,000 | -3.6% | 623 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $56,000 | -20.0% | 623 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $70,000 | -13.6% | 623 | +18.2% | 0.01% | -10.0% |
| Q4 2021 | $81,000 | +11.0% | 527 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $73,000 | +5.8% | 527 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $69,000 | -13.8% | 527 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $80,000 | +27.0% | 527 | -16.3% | 0.01% | +20.0% |
| Q4 2020 | $63,000 | +43.2% | 630 | +36.7% | 0.01% | +25.0% |
| Q3 2020 | $44,000 | +83.3% | 461 | +111.5% | 0.01% | +60.0% |
| Q2 2020 | $24,000 | +71.4% | 218 | +13.5% | 0.01% | +25.0% |
| Q1 2020 | $14,000 | – | 192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |